NO20091912L - Metallkelater med en perfluorert PEG-gruppe, fremgangsmate for fremstilling derav, og anvendelse derav - Google Patents

Metallkelater med en perfluorert PEG-gruppe, fremgangsmate for fremstilling derav, og anvendelse derav

Info

Publication number
NO20091912L
NO20091912L NO20091912A NO20091912A NO20091912L NO 20091912 L NO20091912 L NO 20091912L NO 20091912 A NO20091912 A NO 20091912A NO 20091912 A NO20091912 A NO 20091912A NO 20091912 L NO20091912 L NO 20091912L
Authority
NO
Norway
Prior art keywords
preparation
metal chelates
peg group
perfluorinated peg
perfluorinated
Prior art date
Application number
NO20091912A
Other languages
English (en)
Inventor
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Heiko Schirmer
Bernd Misselwitz
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of NO20091912L publication Critical patent/NO20091912L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oppfinnelsen vedrører gjenstandene som er kjennetegnet i kravene, nemlig metallkelater som har en perfluorert PEG-gruppe, en fremgangsmåte for fremstilling derav og anvendelse derav, en fremgangsmåte for fremstilling derav og anvendelse derav i NMR- og radiologi-diagnostikk, radiodiagnostikk og strålebehandling, og i MRT-lymfografi.
NO20091912A 2006-10-18 2009-05-15 Metallkelater med en perfluorert PEG-gruppe, fremgangsmate for fremstilling derav, og anvendelse derav NO20091912L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102006049821A DE102006049821A1 (de) 2006-10-18 2006-10-18 Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
US85296306P 2006-10-20 2006-10-20
US89007107P 2007-02-15 2007-02-15
PCT/EP2007/007284 WO2008046463A1 (de) 2006-10-18 2007-08-11 Metallchelate mit perfluoriertem peg-rest, verfahren zu deren herstellung sowie deren verwendung

Publications (1)

Publication Number Publication Date
NO20091912L true NO20091912L (no) 2009-07-17

Family

ID=38670854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091912A NO20091912L (no) 2006-10-18 2009-05-15 Metallkelater med en perfluorert PEG-gruppe, fremgangsmate for fremstilling derav, og anvendelse derav

Country Status (21)

Country Link
US (1) US8263040B2 (no)
EP (1) EP2089362A1 (no)
JP (1) JP5475454B2 (no)
KR (1) KR101451446B1 (no)
CN (1) CN101687803B (no)
AU (1) AU2007312691A1 (no)
BR (1) BRPI0717466A2 (no)
CA (1) CA2666910C (no)
CO (1) CO6170342A2 (no)
CR (1) CR10727A (no)
CU (1) CU23837B1 (no)
DE (1) DE102006049821A1 (no)
GT (1) GT200900087A (no)
IL (1) IL198173A0 (no)
MX (1) MX2009004097A (no)
MY (1) MY148553A (no)
NO (1) NO20091912L (no)
NZ (1) NZ576249A (no)
RU (1) RU2470014C2 (no)
SG (1) SG177994A1 (no)
WO (1) WO2008046463A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021948A1 (en) * 2007-08-13 2009-02-19 Ge Healthcare As Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
US11529309B2 (en) * 2016-04-29 2022-12-20 University Of Houston System Compositions, methods and kits for treating a contact lens
WO2019218339A1 (zh) * 2018-05-16 2019-11-21 广州优尔材料科技有限公司 含全氟聚醚基的硅烷化合物、其制备方法、表面处理剂及物品
KR102618166B1 (ko) * 2019-03-29 2023-12-28 다이킨 고교 가부시키가이샤 플루오로폴리에테르기 함유 화합물
AU2024339683A1 (en) 2023-09-13 2026-03-26 Toray Industries, Inc. Pharmaceutical composition for treating, preventing and/or diagnosing cancer

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588279A (en) 1982-10-27 1986-05-13 Konishiroku Photo Industry Co., Ltd. Cleaning roller intermediate transfer member
US4586511A (en) 1983-03-04 1986-05-06 Children's Hospital Medical Center Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance
US4639364A (en) 1984-11-14 1987-01-27 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
EP0292306A3 (en) 1987-05-20 1989-09-13 Nippon Shokubai Co., Ltd. Methylolaminotriazine condensates and method for production thereof
US4838274A (en) 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE4008179A1 (de) 1990-03-12 1991-09-19 Schering Ag Fluorbenzolsulfonamide
US5250283A (en) 1990-03-28 1993-10-05 Molecular Biosystems, Inc. Organic contrast agent analog and method of making same
US5318770A (en) 1991-10-25 1994-06-07 Mallinckrodt Medical, Inc. Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging
DE4203254C2 (de) 1992-02-05 1996-05-02 Max Planck Gesellschaft Fluorhaltige Markierungsverbindung für NMR-Untersuchungen und deren Verwendung
US5482650A (en) 1992-04-28 1996-01-09 Minnesota Mining And Manufacturing Company Liquid crystal compounds having perfluoroether terminal portions
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5401493A (en) 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
DE4317588C2 (de) 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
US5502094A (en) 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5702637A (en) * 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19744003B4 (de) 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
KR20010030854A (ko) 1997-10-02 2001-04-16 로퍼, 랜달 비. 인터벤셔날 요법을 모니터하기 위한 콘트라스트 강화된진단 영상화 방법
DE19914101C1 (de) 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6939329B1 (en) 1999-10-08 2005-09-06 Harvest Technologies Corporation Apparatus for holding and operating one or more syringes
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
RU2206605C1 (ru) * 2002-03-18 2003-06-20 Здоров Юрий Павлович Противоизносная присадка к смазочным средам и топливу
JP2005531647A (ja) * 2002-04-11 2005-10-20 カルボマー インク 新規なイメージングプローブ
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
JP2004101881A (ja) * 2002-09-10 2004-04-02 Konica Minolta Holdings Inc ドライイメージング材料
EP1713513B1 (en) 2004-01-16 2014-06-04 Carnegie Mellon University Cellular labeling for nuclear magnetic resonance techniques
RU2296756C2 (ru) * 2005-05-17 2007-04-10 Федеральное унитарное государственное предприятие "Государственный научно-исследовательский институт биологического приборостроения" (ГосНИИ БП) Комплексообразующие дибензосодержащие пятичленные циклические соединения, содержащие два симметричных бета-дикарбонильных заместителя с фторированными радикалами

Also Published As

Publication number Publication date
RU2009118486A (ru) 2010-11-27
DE102006049821A1 (de) 2008-04-24
CU20090059A7 (es) 2011-03-21
CR10727A (es) 2009-07-23
IL198173A0 (en) 2009-12-24
BRPI0717466A2 (pt) 2014-04-15
US20080159954A1 (en) 2008-07-03
CN101687803A (zh) 2010-03-31
RU2470014C2 (ru) 2012-12-20
JP2010506862A (ja) 2010-03-04
WO2008046463A1 (de) 2008-04-24
SG177994A1 (en) 2012-02-28
KR101451446B1 (ko) 2014-10-16
NZ576249A (en) 2012-03-30
AU2007312691A1 (en) 2008-04-24
EP2089362A1 (de) 2009-08-19
CU23837B1 (es) 2012-10-15
CA2666910C (en) 2013-12-24
HK1141526A1 (en) 2010-11-12
KR20090082222A (ko) 2009-07-29
MX2009004097A (es) 2009-07-10
MY148553A (en) 2013-04-30
CA2666910A1 (en) 2008-04-24
CO6170342A2 (es) 2010-06-18
US8263040B2 (en) 2012-09-11
JP5475454B2 (ja) 2014-04-16
CN101687803B (zh) 2012-05-30
GT200900087A (es) 2010-04-19

Similar Documents

Publication Publication Date Title
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
GB2476551B (en) Methods for treating superalloy articles, and related repair processes
GB0721285D0 (en) Method for tomographic inversion by matrix transformation
BRPI0717416A2 (pt) Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo
DE112010000702B8 (de) Hochfestes, abgeschrecktes Formteil und Verfahren zu dessen Herstellung
BR112013011406A2 (pt) aço para molas de alta resistência, método para produção de molas de alta resistência, e mola de alta resistência
EP2392683A4 (en) HIGH TEMPERATURE GALVANIZED HOT-DIP STEEL SHEET AND METHOD OF MANUFACTURING THE SAME
IL187586A0 (en) Method for producing dihydroquinazolines
EP2034844A4 (en) METHOD OF TREATING IRRITABLE COLON SYNDROME WITH PREDOMINANT DIARRHEA
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
EP2808417A4 (en) STEEL SHEET FOR HOT BOWLING, METHOD FOR MANUFACTURING THE SAME, AND PROCESS FOR PRODUCING HOT BOTTOM USING THE SAME
DE502007002301D1 (de) Verfahren zum Herstellen von Ventilgehäusen
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
WO2009094717A3 (en) A method of inducing tolerance to an allergen
DE502006004266D1 (de) Luftsack, und verfahren zum herstellen eines gewebes für einen luftsack
BRPI0911531A2 (pt) processo para preparar iopromida, e, composto.
GEP20156221B (en) Agomelatine hydrohalide complex and preparation method thereof
NO20091912L (no) Metallkelater med en perfluorert PEG-gruppe, fremgangsmate for fremstilling derav, og anvendelse derav
CY1115577T1 (el) Μεθοδος για την παρασκευη εναντιομερικως καθαρων αμινων
DK1994005T3 (da) Tetrahydronaphthalinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelseshæmmere
AT10460U3 (de) Prüfstands-konditioniersystem für ein arbeitsfluid, sowie vorrichtung zum betreiben eines derartigen prüfstands-konditioniersystems
MX2015005981A (es) Preparacion de intermediarios de agentes de contraste de rayos x.
SG126028A1 (en) Method for processing a set of spectra, particularly nmr spectra
DE602005007157D1 (de) Verfahren für Arylamine Produktion
TW200740777A (en) Perfluoroalkyl-containing complexes, process for their production as well as their use

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

FC2A Withdrawal, rejection or dismissal of laid open patent application